The DOI matches its Crossref record; 158 of the 159 references it cites were found in a registry or an index.
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Abstract
Tissue hypoxia results from an inadequate supply of oxygen (O(2)) that compromises biologic functions. Evidence from experimental and clinical studies increasingly points to a fundamental role for hypoxia in solid tumors. Hypoxia in tumors is primarily a pathophysiologic consequence of structurally and functionally disturbed microcirculation and the deterioration of diffusion conditions. Tumor hypoxia appears to be strongly associated with tumor propagation, malignant progression, and resistance to therapy, and it has thus become a central issue in tumor physiology and cancer treatment. Biochemists and clinicians (as well as physiologists) define hypoxia differently; biochemists define it as O(2)-limited electron transport, and physiologists and clinicians define it as a state of reduced O(2) availability or decreased O(2) partial pressure that restricts or even abolishes functions of organs, tissues, or cells. Because malignant tumors no longer execute functions necessary for homeostasis (such as the production of adequate amounts of adenosine triphosphate), the physiology-based definitions of the term "hypoxia" are not necessarily valid for malignant tumors. Instead, alternative definitions based on clinical, biologic, and molecular effects that are observed at O(2) partial pressures below a critical level have to be applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
(1989) · PubMed · Cited by 3,343
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,891
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Self-citation
Research works printed but not linked: 35
- Brown, 1998, Cancer Research, 58, 1408
- Hockel, 1996, Cancer Research, 56, 4509
- Brizel, 1996, Cancer Research, 56, 941
- Walenta, 2000, Cancer Research, 60, 916
- Hockel, 1999, Cancer Research, 59, 4525
- Kim, 1997, Cancer Research, 57, 4200
- Anthoney, 1996, Cancer Research, 56, 1374
- Vaupel, 1989, Cancer Research, 49, 6449
- Vaupel, 1987, Cancer Research, 47, 3496
- Kallinowski, 1989, Cancer Research, 49, 3759
- 1973, Advances in experimental medicine and biology, 37, 277
- Vaupel, 1991, Cancer Research, 51, 3316
- Hockel, 1991, Cancer Research, 51, 6098
- Wilson, 1992, Cancer Research, 52, 3988
- 1996, BRITISH JOURNAL OF CANCER, 74, S226
- Valk, 1992, Journal of Nuclear Medicine, 33, 2133
- Groshar, 1993, Journal of Nuclear Medicine, 34, 885
- Lord, 1993, Cancer Research, 53, 5721
- Evans, 1996, Cancer Research, 56, 405
- Riva, 1998, Anticancer Research, 18, 4729
- Prehn, 1991, Cancer Research, 51, 2
- Ausserer, 1994, Molecular and Cellular Biology, 14, 5032, 10.1128/mcb.14.8.5032 · DOI
- Hartmann, 1999, Cancer Research, 59, 1578
- Koong, 1994, Cancer Research, 54, 1425
- Henderson, 1987, Cancer Research, 47, 3110
- Mitchell, 1985, Cancer Research, 45, 2008
- Reynolds, 1996, Cancer Research, 56, 5754
- Stoler, 1992, Cancer Research, 52, 4372
- Russo, 1995, Cancer Research, 55, 1122
- Teicher, 1990, Cancer Research, 50, 3339
- Teicher, 1981, Cancer Research, 41, 73
- Moan, 1985, Cancer Research, 45, 1608
- 1981, Bibliotheca anatomica, 20, 628
- 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 46, S107
- 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48, S162
Cited by
Sorted by citations
Items 501–600 of 1,008
Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Graves, E. E., Vilalta, M., Cecić, I., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1206 · Cited by 87
Goh, V., Halligan, S., Wellsted, D. M., & Bartram, C. I. (2008) · European Radiology · doi:10.1007/s00330-008-1128-1 · Cited by 88
Hypoxia Selection of Death-resistant Cells
Dong, Z., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312225200 · Cited by 86
Serine-dependent redox homeostasis regulates glioblastoma cell survival
Engel, A. L., Lorenz, N. I., Klann, K., Münch, C., Depner, C., Steinbach, J. P., Ronellenfitsch, M. W., & Luger, A.-L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0794-x · Cited by 85
Cho, S., Lee, H., Jeong, S., Lee, H., Kim, H., Chen, C. Y., Lee, E., & Kim, S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00865.x · Cited by 86
Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma
Coffman, L. G., Pearson, A. T., Frisbie, L. G., Freeman, Z. T., Christie, E. L., Bowtell, D. D. L., & Buckanovich, R. J. (2018) · Stem Cells · doi:10.1002/stem.2932 · Cited by 83
Tsuji, A., Akao, T., Masuya, T., Murai, M., & Miyoshi, H. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013366 · Cited by 84
Vaupel, P. W., Mayer, A., Briest, S., & Höckel, M. (2006) · Springer eBooks · doi:10.1007/0-387-26206-7_44 · Cited by 85
Self-citationHypoxic Tumor Microenvironments Reduce Collagen I Fiber Density
Kakkad, S. M., Solaiyappan, M., O'Rourke, B. P., Stasinopoulos, I. A., Ackerstaff, E., Raman, V., Bhujwalla, Z. M., & Glunde, K. (2010) · Neoplasia · doi:10.1593/neo.10344 · Cited by 86
Tumor oxygenation status as a prognostic marker
Menon, C., & Fraker, D. L. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.029 · Cited by 86
Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues
Sánchez‐González, P., López-Hernández, F. J., Dueñas, M., Prieto, M., Sánchez‐López, E., Thomale, J., Ruiz‐Ortega, M., López-Novoa, J. M., & Morales, A. I. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.06.047 · Cited by 87
Babii, O., Afonin, S., Garmanchuk, L., Nikulina, V. V., Nikolaienko, T. V., Storozhuk, O. V., Шелест, Д. В., Dasyukevich, O. I., Остапченко, Л. І., Iurchenko, V., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201600506 · Cited by 85
A turn-on fluorescent probe for tumor hypoxia imaging in living cells
Cai, Q., Yu, T., Zhu, W. P., Xu, Y. F., & Qian, X. H. (2015) · Chemical Communications · doi:10.1039/c5cc05518k · Cited by 85
Onishi, H., Kai, M., Odate, S., Iwasaki, H., Morifuji, Y., Ogino, T., Morisaki, T., Nakashima, Y., & Katano, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01912.x · Cited by 85
Kaper, F., Dornhöfer, N., & Giaccia, A. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3375 · Cited by 87
Cui, L., Tse, K. C. K., Zahedi, P., Harding, S. M., Zafarana, G., Jaffray, D. A., Bristow, R. G., & Allen, C. J. (2014) · Radiation Research · doi:10.1667/rr13642.1 · Cited by 83
CXCR4 as biomarker for radioresistant cancer stem cells
Trautmann, F., Cojoc, M., Kurth, I., Mélin, N., Bouchez, L. C., Dubrovska, A., & Peitzsch, C. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.906766 · Cited by 90
Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
Feng, H., Wang, J., Chen, W., Shan, B., Guo, Y., Xu, J., Wang, L., Guo, P., & Zhang, Y. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.001 · Cited by 86
Yu, J., Rak, J. W., Klement, G. L., & Kerbel, R. S. (2002) · PubMed · Cited by 85
Changing the energy of an immune response.
Delmastro-Greenwood, M. M., & Piganelli, J. D. (2013) · Europe PMC (PubMed Central) · Cited by 84
Pawlus, M. R., & Hu, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.018 · Cited by 85
Cellular Signal Transduction of the Hypoxia Response
Nakayama, K. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp167 · Cited by 84
Mitochondria and Energetic Depression in Cell Pathophysiology
Seppet, E. K., Puurand, M., Peetsalu, A., Gizatullina, Z. Z., Nguyen, H. P., Vielhaber, S., Wussling, M. H. P., Trumbeckaitė, S., Arandarčikaitė, O., Jerzembek, D., et al. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10052252 · Cited by 84
A3 Adenosine Receptors Modulate Hypoxia-inducible Factor-1a Expression in Human A375 Melanoma Cells
Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., Baraldi, P. G., & Borea, P. A. (2005) · Neoplasia · doi:10.1593/neo.05334 · Cited by 85
Palayoor, S. T., Tofilon, P. J., & Coleman, C. N. (2003) · PubMed · Cited by 83
Recent advances in pancreatic cancer: biology, treatment, and prevention
Singh, D. K., Upadhyay, G., Srivastava, R. K., & Shankar, S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.04.003 · Cited by 85
Near-Infrared Optical Mammography for Breast Cancer Detection with Intrinsic Contrast
Fantini, S., & Sassaroli, A. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0404-4 · Cited by 89
Liu, T., Zhao, L., Zhang, Y., Chen, W., Liu, D., Hou, H., Ding, L., & Xu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103887 · Cited by 85
Hypoxia in head and neck cancer
Isa, A., Ward, T. H., West, C., Slevin, N. J., & Homer, J. J. (2006) · British Journal of Radiology · doi:10.1259/bjr/17904358 · Cited by 86
Shapiro, J., ten Kate, F. J. W., van Hagen, P., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6191d · Cited by 83
Is the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths, E. A., Pritchard, S., Welch, I., Price, P., & West, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.008 · Cited by 83
Zhang, Q., Zhang, Z., Rao, J. Y., Sato, J. D., Brown, J. J., Messadi, D. V., & Le, A. D. (2004) · International Journal of Cancer · doi:10.1002/ijc.20334 · Cited by 83
Lee, C., Lim, K., Kim, S. S., Thien, L. X., Lee, E. S., Oh, K. T., Choi, H., & Youn, Y. S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.011 · Cited by 86
Saccharin: A lead compound for structure-based drug design of carbonic anhydrase IX inhibitors
Mahon, B. P., Hendon, A. M., Driscoll, J. M., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.030 · Cited by 82
The resolution of inflammation and cancer
Rodríguez‐Vita, J., & Lawrence, T. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.006 · Cited by 83
Reduced Levels of ATF-2 Predispose Mice to Mammary Tumors
Maekawa, T., Shinagawa, T., Sano, Y., Sakuma, T., Nomura, S., Nagasaki, K., Miki, Y., Saito-Ohara, F., Inazawa, J., Kohno, T., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01579-06 · Cited by 82
Li, H., Xu, F., Li, S., Zhong, A., Meng, X., & Lai, M. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1129481 · Cited by 85
PEG‐fibrinogen hydrogels for three‐dimensional breast cancer cell culture
Pradhan, S., Hassani, I., Seeto, W. J., & Lipke, E. A. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35899 · Cited by 82
Jiang, L., Chughtai, K., Purvine, S. O., Bhujwalla, Z. M., Raman, V., Paša‐Tolić, L., Heeren, R. M. A., & Glunde, K. (2015) · Analytical Chemistry · doi:10.1021/ac504503x · Cited by 81
Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle
Jiang, J. H., Wang, N., Li, A., Liao, W., Pan, Z.-G., Mai, S., Li, D.-J., Zeng, M., Wen, J., & Zeng, Y.-X. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.06.013 · Cited by 81
Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
Zhang, D., Shi, Z., Li, M., & Mi, J. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.240 · Cited by 81
NO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells
Zhou, J., Fandrey, J., Schümann, J., Tiegs, G., & Brüne, B. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00294.2002 · Cited by 81
Tateishi, K., Tateishi, U., Sato, M., Yamanaka, S., Kanno, H., Murata, H., Inoue, T., & Kawahara, N. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3159 · Cited by 81
Hussein, D., Estlin, E. J., Dive, C., & Makin, G. W. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0145 · Cited by 80
“A, Western blot showing levels of HIF1a in stable shRNA interference knockdown clones of SH-EP1 (1) and SH-SY5Y (3) cells.”
BackgroundNanomedicines Targeting the Tumor Microenvironment
Tong, R., & Langer, R. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000123 · Cited by 79
Regulatory Networks of LncRNA MALAT-1 in Cancer
Fu, S., Wang, Y., Li, H., et al. (2020) · Cancer Management and Research · doi:10.2147/cmar.s276022 · Cited by 80
Obaid, M., Udden, S. M. N., Alluri, P. G., & Mandal, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-80291-4 · Cited by 83
Chen, X., Liu, J., Li, Y., Pandey, N. K., Chen, T., Wang, L., Amador, E. H., Chen, W., Liu, F., Xiao, E., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.016 · Cited by 80
The Hidden Role of Hydrogen Sulfide Metabolism in Cancer
Wang, R., Chu, Y.-H., & Lin, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126562 · Cited by 80
Fang, Z., Wang, C., Yang, J., Song, Z., Xie, C., Ji, Y., Wang, Z., Du, X., Zheng, Q., Chen, C., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01501-4 · Cited by 84
Dhani, N. C., Serra, S., Pintilie, M., Schwock, J., Xu, J., Gallinger, S., Hill, R. P., & Hedley, D. W. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.284 · Cited by 83
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer
Rivenzon‐Segal, D., Boldin‐Adamsky, S., Seger, D., Seger, R., & Degani, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11387 · Cited by 80
Chakraborty, G., Rangaswami, H., Jain, S., & Kundu, G. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512546200 · Cited by 81
The Evolving, Multifaceted Roles of Autophagy in Cancer
Liu, J., & Debnath, J. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.005 · Cited by 82
Zhang, C., Yang, C., Feldman, M. J., Wang, H., Pang, Y., Maggio, D. M., Zhu, D., Nesvick, C. L., Dmitriev, P., Bullova, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18125 · Cited by 80
Koyasu, S., Nakamoto, Y., Kikuchi, M., Suzuki, K., Hayashida, K., Itoh, K., & Togashi, K. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11013 · Cited by 80
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells
Dando, I., Cordani, M., Pozza, E. D., Biondani, G., Donadelli, M., & Palmieri, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/425708 · Cited by 79
Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells
Han, J., Li, J., Ho, J. C., Chia, G. S., Kato, H., Jha, S., Yang, H. H., Poellinger, L., & Lee, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04333-0 · Cited by 84
Ziani, L., Buart, S., Chouaı̈b, S., & Thiery, J. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1950953 · Cited by 82
A domain responsible for HIF-1α degradation by YC-1, a novel anticancer agent
Kim, H.-L., Yeo, E.-J., Chun, Y., & Park, J. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.255 · Cited by 79
Tumor Oxygen Dynamics: Correlation of In Vivo MRI with Histological Findings
Zhao, D., Ran, S., Constantinescu, A., Hahn, E. W., & Mason, R. P. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80024-6 · Cited by 79
Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy
Choe, R., & Durduran, T. (2011) · IEEE Journal of Selected Topics in Quantum Electronics · doi:10.1109/jstqe.2011.2177963 · Cited by 79
Kuroda, S., Fujiwara, T., Shirakawa, Y., Yamasaki, Y., Yano, S., Uno, F., Tazawa, H., Hashimoto, Y., Watanabe, Y., Noma, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2333 · Cited by 79
Ivey, J. W., Bonakdar, M., Kanitkar, A., Davalos, R. V., & Verbridge, S. S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.019 · Cited by 83
Sun, L., Chen, Y., Kuang, S., Li, G., Guan, R., Liu, J., Ji, L., & Chao, H. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600310 · Cited by 79
Rofstad, E. K., Mathiesen, B. S., & Galappathi, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2658 · Cited by 79
Re: Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
Costa, A., Coradini, D., Carrassi, A., Erdas, R., Sardella, A., & Daidone, M. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1175-a · Cited by 79
Baba, K., Kitajima, Y., MIYAKE, S., Nakamura, J., Wakiyama, K., Sato, H., Okuyama, K., Kitagawa, H., Tanaka, T., Hiraki, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11769-x · Cited by 75
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
Foltyn‐Dumitru, M., Luger, A., Lorenz, N. I., Sauer, B., Mittelbronn, M. G. A., Harter, P. N., Steinbach, J., & Ronellenfitsch, M. W. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0368-3 · Cited by 78
Regulation of cancer metastasis by stress pathways
Xie, K., & Huang, S. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022590402748 · Cited by 80
Cellular reaction to hypoxia: sensing and responding to an adverse environment
Papandreou, I., Powell, A. A., Lim, A. L., & Denko, N. C. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.054 · Cited by 77
Hypoxia Markers in Human Osteosarcoma: An Exploratory Study
Mizobuchi, H., García-Castellano, J. M., Philip, S., Healey, J. H., & Gorlick, R. G. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0328-y · Cited by 77
Generali, D., Fox, S. B., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Wigfield, S., Bruzzi, P., Bersiga, A., Allevi, G., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01216 · Cited by 79
Hypoxia-Induced Signaling in the Cardiovascular System
Simon, M. C., Liu, L., Barnhart, B. C., & Young, R. M. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100526 · Cited by 82
Non-Angiogenic Functions of VEGF in Breast Cancer
Mercurio, A. M., Lipscomb, E. A., & Bachelder, R. E. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9001-9 · Cited by 81
Terry, S., Buart, S., Tan, T. Z., Gros, G., Noman, M. Z., Lorens, J. B., Mami‐Chouaib, F., Thiery, J. P., & Chouaı̈b, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1271858 · Cited by 82
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis
Gomez‐Manzano, C., Fueyo-Margareto, J., Jiang, H., Glass, T. L., Lee, H., Hu, M., Liu, J.-L., Jasti, S. L., Liu, T., Conrad, C. A., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10396 · Cited by 78
Basudhar, D., Bharadwaj, G., Cheng, R. Y. S., Jain, S., Shi, S., Heinecke, J. L., Holland, R. J., Ridnour, L. A., Caceres, V., Spadari-Bratfisch, R. C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400196q · Cited by 78
Lucien, F., Brochu‐Gaudreau, K., Arsenault, D., Harper, K., & Dubois, C. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028851 · Cited by 77
Han, Y., Chen, Z., Zhao, H., Zha, Z., Ke, W., Wang, Y., & Ge, Z. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.012 · Cited by 79
Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence
Das, D. M., & Law, S. K. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.08.011 · Cited by 81
Raa, A., Stansberg, C. T., Steen, V. M., Bjerkvig, R., Reed, R. K., & Stuhr, L. E. B. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-23 · Cited by 77
The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
Hoogsteen, I. J., Marres, H. A. M., van der Kogel, A. J., & Kaanders, J. H. A. M. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.001 · Cited by 77
Riemann, A., Rauschner, M., Gießelmann, M., Reime, S., Haupt, V., & Thews, O. (2019) · Neoplasia · doi:10.1016/j.neo.2019.03.004 · Cited by 75
Therapeutic strategies to remodel immunologically cold tumors
Wang, M., Wang, S., Desai, J., Trapani, J. A., & Neeson, P. J. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1226 · Cited by 79
Swartz, J. E., Pothen, A. J., Stegeman, I., Willems, S. M., & Grolman, W. (2015) · Cancer Medicine · doi:10.1002/cam4.460 · Cited by 78
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin
Wang, Y., Li, S., & Liao, J.-X. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500343 · Cited by 76
Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
Misra, A., Pandey, C., Sze, S. K., & Thanabalu, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049766 · Cited by 83
Cell-ECM Interactions in Tumor Invasion
He, X., Lee, B., & Jiang, Y. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42023-3_4 · Cited by 79
Ron, A., Deán‐Ben, X. L., Gottschalk, S., & Razansky, D. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3769 · Cited by 76
Stuhr, L. E. B., Raa, A., Øyan, A. M., Kalland, K. H., Sakariassen, P. O., Petersen, K., Bjerkvig, R., & Reed, R. K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9407-2 · Cited by 76
“Thus, HbO2 saturation has been shown to be significantly lower in tumors than in normal surrounding tissue with a gradual reciprocal decrease as the tumor increases in size [1, 2].”
BackgroundPreclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading
Shin, D. H., Kim, J.-H., Jung, Y.-J., Kim, K.-E., Jeong, J. M., Chun, Y.-S., & Park, J.-W. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.026 · Cited by 83
Sorg, B. S., Hardee, M. E., Agarwal, N., Moeller, B. J., & Dewhirst, M. W. (2008) · Journal of Biomedical Optics · doi:10.1117/1.2837439 · Cited by 75
Exosomes: Biogenesis, Composition, Functions, and Their Role in Pre-metastatic Niche Formation
Patil, A. A., & Rhee, W. J. (2019) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-019-0170-y · Cited by 75
Titz, B., & Jeraj, R. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/17/001 · Cited by 75
Hara, S., Nakashiro, K., Klosek, S. K., Ishikawa, T., Shintani, S., & Hamakawa, H. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.10.016 · Cited by 75
Yoshii, Y., Yoneda, M., Ikawa, M., Furukawa, T., Kiyono, Y., Mori, T., Yoshii, H., Oyama, N., Okazawa, H., Saga, T., et al. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.08.008 · Cited by 75
Cap-independent regulation of gene expression in apoptosis
Graber, T. E., & Holčı́k, M. (2007) · Molecular BioSystems · doi:10.1039/b708867a · Cited by 75
Zat'ovičová, M., Tarábková, K., Švastová, E., Gibadulinová, A., Mucha, V., Jakubı&#x;čková, L., Biesová, Z., Rafajová, M., Gut, M. O., Parkkila, S., et al. (2003) · Journal of Immunological Methods · doi:10.1016/j.jim.2003.08.011 · Cited by 75
Grist, S. M., Nasseri, S. S., Laplatine, L., Schmok, J. C., Yao, D. R., Hua, J., Chrostowski, L., & Cheung, K. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-54001-8 · Cited by 76
Metadata
- Authors
- Hockel, M., & Vaupel, P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, P.
- ORCID
- Vaupel, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-21
- Volume
- 93
- Issue
- 4
- Pages
- 266-276
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2125257427
- Semantic Scholar
- 6c70b98add72efaae8670b5183983be403de59ae
- Cited by
- 2,662
- References
- 159
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 93 · 2023: 134 · 2022: 110 · 2021: 139 · 2020: 149 · 2019: 120 · 2018: 110 · 2017: 148 · 2016: 143 · 2015: 123 · 2014: 114 · 2013: 104 · 2012: 114
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tissue hypoxia, solid tumors, tumor microcirculation, oxygen partial pressure, tumor progression, treatment resistance, tumor physiology, oxygen diffusion
- MeSH terms
- Animals, Humans, Neoplasms, Oxygen, Predictive Value of Tests, Prognosis, Risk Factors, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review